Breast Biopsy tests are used for diagnosing breast cancer and also act as a preventive screening method for the same and other ailments in breast, such as lump. The market is driven by increasing count of breast cancer, increasing awareness regarding breast cancer screening programs along with new reimbursement guidelines for biopsy procedures in the U.S. are the key factors that drive the growth of this market. Furthermore, increasing demand for breast surgeries that are minimally invasive is expected to boost the market growth. Various regulatory issues and risks of infection in breast biopsy procedures are key restraining factors that may hinder the growth of the market. Emerging countries is expected to offer abundant growth opportunities to the breast biopsy market.
The market is segmented on the basis of products, types, guidance and region. On the basis of product, the market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires and others. On the basis of types, the market is segmented into needle breast biopsy and open surgical breast biopsy where the former is segmented into Core-Needle Biopsy (CNB), fine-needle aspiration biopsy (FNAB) and vacuum-assisted biopsy (VAB) while the latter is segmented into excisional breast biopsy and incisional breast biopsy. On the basis of guidance, the market is segmented into mammography-guided stereotactic breast biopsy, ultrasound-guided breast biopsy, MRI-guided breast biopsy and other guidance techniques. On the basis of region, the market is segmented into North America, Asia-Pacific, and Europe.
Key market players operating in this market are Becton, Dickinson and Company, C.R. Bard, Inc., Devicor Medical Products Inc., Hologic Inc., Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC, Ethicon Endo Surgery (Johnson and Johnson and Galini SRL.
KEY BENEFITS FOR STAKEHOLDERS:
- The report provides a comprehensive analysis of current & future market trends and emerging avenues for the growth of this market globally.
- The report offers an overview of changing market dynamics in terms of fast turn-around analysis of stakeholders responses to recent industry policy changes and trends.
- The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
- This report entails the detailed quantitative analysis of the current market and estimations through 2014 and 2020, which assists in identifying the prevailing opportunities.
- Recent developments in government policies on various segments is highlighted along with offering insight into the regulatory framework impacting the market.
- The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.
- The report offers the competitive landscape scenario in terms of the strategies adopted by key industry players to consolidate their market presence.
KEY MARKET SEGMENTS:
- Market By Product
- Biopsy Needles
- Guidance Systems
- Biopsy Tables
- Localization Wires
- Market By Type
- Needle Breast Biopsy
- Core-Needle Biopsy (CNB)
- Fine-Needle Aspiration Biopsy (FNAB)
- Vacuum-Assisted Biopsy (VAB)
- Open Surgical Breast Biopsy
- Excisional Breast Biopsy
- Incisional Breast Biopsy
- Market By Guidance
- Mammography-Guided Stereotactic Breast Biopsy
- Ultrasound-Guided Breast Biopsy
- MRI-Guided Breast Biopsy
- Other Guidance Techniques
- Market By Region
- North America
- Key Market Player
- Dickinson and Company
- C.R. Bard, Inc.
- Devicor Medical Products Inc.
- Hologic Inc.
- Argon Medical Devices
- Cook Medical Incorporated
- Encapsule Medical Devices LLC
- Ethicon Endo Surgery